Oumar Sy

1.9k citations

53 papers · 1.3k indexed · h-index 16

Impact in

Hematology top 2%
- Chronic Myeloid Leukemia Treatments
- Multiple Myeloma Research and Treatments
Genetics top 5%
- Chronic Lymphocytic Leukemia Research

Papers in

Hematology 26
- Chronic Myeloid Leukemia Treatments 19
- Multiple Myeloma Research and Treatments 7
Genetics 18
- Chronic Lymphocytic Leukemia Research 15

Co-authors: Lewis C. Strauss Joseph A. Sparano Justin Fairchild David A. Dzewaltowski Karen J. Coleman Carmelo Bengala Edward M. Heath George A. Milliken
Journals: Blood (6 papers)HemaSphere (5 papers)Journal of Clinical Oncology (4 papers)Clinical Cancer Research (3 papers)Cancer Research (3 papers)
Partner nations: United States France Germany

In The Last Decade

Oumar Sy

49 papers receiving 1.2k citations

Peers

Countries citing papers authored by Oumar Sy

Since Specialization

Citations

This map shows the geographic impact of Oumar Sy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oumar Sy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oumar Sy more than expected).

Fields of papers citing papers by Oumar Sy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oumar Sy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oumar Sy. The network helps show where Oumar Sy may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Oumar Sy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Oumar Sy Line = papers co-authored together Oumar Sy links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Treatment of chronic-phase chronic myeloid leukemia in patients randomized to dasatinib or imatinib after suboptimal responses to 3 months of imatinib therapy: final 5-year results from DASCERN Haematologica ·Jörge E. Cortes, Qian Jiang, Jianxiang Wang, Yan Haijiang, Huanling Zhu, Xiaoli Liu, Andreas Hochhaus, Dong‐Wook Kim, Jerald P. Radich, Michael R. Savona, Patricia Martin‐Regueira, Oumar Sy, Giuseppe Saglio	2024	1
2	Safety and efficacy of fedratinib, a selective oral inhibitor of Janus kinase‐2 (JAK2), in patients with myelofibrosis and low pretreatment platelet counts British Journal of Haematology ·Claire Harrison, Nicolaas Schaap, Alessandro M. Vannucchi, Jean‐Jacques Kiladjian, Francesco Passamonti, Sonja Zweegman, Moshe Talpaz, Srđan Verstovšek, Shelonitda Rose, Jun Zhang, Oumar Sy, Ruben A. Mesa	2022	24
3	Association of high SARS-CoV-2 RNAemia with diabetes and mortality in critically ill COVID-19 patients iScience ·Mehran Monchi, В. С. Ратников, Sébastien Jochmans, David Veyer, A. Pitsch, J.M. Hurakadli, Leidy Alejandra Ramírez, Valérie Taly, Oumar Sy, Aria Nur Farida Muslicha, S. Diamantis, Hélène Péré	2022	6
4	Dynamique de la mangrove et perceptions locales dans le Département d’Oussouye (Basse-Casamance, Sénégal) entre 1972 et 2018 SHILAP Revista de lepidopterología ·John Alcorn, J. Ekelmans, Maryna A. Tryfanenkava, Diviya Thilakeswaran, Yasantha R. Rajapakse, Oumar Sy, Josep Ma Ribera, Nur Ila Ifawati, TAKAMITSU NAGATA, Catherine Méring, Amadou Tahirou Diaw	2022	2
5	Stratégies des acteurs de l’aviculture commerciale à Ziguinchor, Sénégal Revue d’élevage et de médecine vétérinaire des pays tropicaux ·A. Balasuriya, A-C. Salaün, Oumar Sy	2022	2
6	Automated vs. conventional ventilation in the ICU: a randomized controlled crossover trial comparing blood oxygen saturation during daily nursing procedures (I-NURSING) Critical Care ·Jonathan Chelly, Aria Nur Farida Muslicha, Sébastien Jochmans, B.S. Bernstein, Franck Pourcine, J.M. Hurakadli, Nathalie Thieulot-Rolin, Joachim Becht, Oumar Sy, Ly Van Vong, Mehran Monchi	2020	9
7	Dasatinib vs. imatinib in patients with chronic myeloid leukemia in chronic phase (CML-CP) who have not achieved an optimal response to 3 months of imatinib therapy: the DASCERN randomized study Leukemia ·Jörge E. Cortes, Qian Jiang, Jianxiang Wang, Jianyu Weng, Huanling Zhu, Xiaoli Liu, Andreas Hochhaus, Dong‐Wook Kim, Jerald P. Radich, Michael R. Savona, Patricia Martin‐Regueira, Oumar Sy, Yale Univ, Giuseppe Saglio	2020	35
8	Duration of prone position sessions: a prospective cohort study Annals of Intensive Care ·Sébastien Jochmans, Aria Nur Farida Muslicha, Jonathan Chelly, Franck Pourcine, Oumar Sy, Nathalie Thieulot-Rolin, J.M. Hurakadli, Peter F. Burke, Радик Рашитович Ишмухаметов, Joachim Becht, Christophe Vinsonneau, Ly Van Vong, Mehran Monchi	2020	31
9	Dasatinib discontinuation in patients with chronic-phase chronic myeloid leukemia and stable deep molecular response: the DASFREE study Leukemia & lymphoma ·Neil P. Shah, Valentín García‐Gutiérrez, Antonio Jiménez‐Velasco, Sarah M. Larson, Susanne Saußele, Delphine Réa, François‐Xavier Mahon, Moshe Levy, María Teresa Gómez‐Casares, Fabrizio Pane, Franck‐Emmanuel Nicolini, Michael J. Mauro, Oumar Sy, Patricia Martin‐Regueira, Jeffrey H. Lipton	2019	97
10	Treatment-Free Remission (TFR) in Patients with Chronic-Phase Chronic Myeloid Leukemia (CML-CP) and Stable Deep Molecular Response (DMR) Discontinuing Dasatinib (DASFREE) Clinical Lymphoma Myeloma & Leukemia ·Neil P. Shah, Andersom José Moreira de Oliveira Melo, Antonio Jiménez‐Velasco, Sarah M. Larson, Susanne Saußele, Delphine Réa, François‐Xavier Mahon, Moshe Levy, María Teresa Gómez‐Casares, Fabrizio Pane, Franck‐Emmanuel Nicolini, Michael J. Mauro, Oumar Sy, Patricia Martin‐Regueira, Jeffrey H. Lipton	2018	1
11	Does metformin exposure before ICU stay have any impact on patients’ outcome? A retrospective cohort study of diabetic patients Annals of Intensive Care ·Sébastien Jochmans, Iris J. Koele, Jonathan Chelly, Ly Van Vong, Oumar Sy, Nathalie Rolin, J.M. Hurakadli, Mehran Monchi, Christophe Vinsonneau	2017	15
12	Novel lung imaging biomarkers and skin gene expression subsetting in dasatinib treatment of systemic sclerosis-associated interstitial lung disease PLoS ONE ·Viktor Martyanov, Grace Hyun J. Kim, Wendy Hayes, Shuyan Du, Bishu Ganguly, Oumar Sy, Joy Baldridge, Galina S. Bogatkevich, Gary L. Schieven, Elena Schiopu, Roberta Gonçalves Marangoni, Jonathan Goldin, Michael L. Whitfield, John Varga	2017	58
13	Une série continue de 27 patients adultes opérés d’un spondylolisthésis isthmique L5-S1 par voie combinée : résultats cliniques et radiologiques à 1 an de suivi Neurochirurgie ·N’golo Abdoulaye Koné, Wenyan Yang, de Vries-van Rossen A, Taher Hassan, R. Parra Quezada, Oumar Sy, 幸雄塩形, Cédric Barrey	2017	1
14	Dasatinib plus Capecitabine for Advanced Breast Cancer: Safety and Efficacy in Phase I Study CA180004 Clinical Cancer Research ·George Somlo, Francesco Atzori, Lewis C. Strauss, William J. Geese, Jennifer M. Specht, William J. Gradishar, ESRA GÜRKAŞ, Oumar Sy, Linda T. Vahdat, Javier Cortés	2013	36
15	Evaluation of Blind Nasotracheal Suctioning and Non-bronchoscopic Mini-Bronchoalveolar Lavage in Critically Ill Patients with Infectious Pneumonia: A Preliminary Study Respiratory Care ·Marie Hartmann, Hélène Rousseau, J Maillet, Stéphane Thierry, Oumar Sy, Éric Vicaut, Fabrice Thiollière, G. Choukroun, Karim Chergui, Guillaume Chevrel, Éric Maury	2013	8
16	Dasatinib as a Single Agent in Triple-Negative Breast Cancer: Results of an Open-Label Phase 2 Study Clinical Cancer Research ·Richard S. Finn, Carmelo Bengala, Nuhad K. Ibrahim, Henri Roché, Joseph A. Sparano, Lewis C. Strauss, Justin Fairchild, Oumar Sy, Lori J. Goldstein	2011	187
17	A Phase 2 Trial of Dasatinib in Patients with Advanced HER2-Positive and/or Hormone Receptor–Positive Breast Cancer Clinical Cancer Research ·Erica L. Mayer, Jean‐François Baurain, Joseph A. Sparano, Lewis C. Strauss, Mario Campone, P. Fumoleau, Hope S. Rugo, Ahmad Awada, Oumar Sy, Antonio Llombart‐Cussac	2011	82
18	Phase 1 pharmacokinetic and drug‐interaction study of dasatinib in patients with advanced solid tumors Cancer ·Faye M. Johnson, Shruti Agrawal, Howard A. Burris, Lee S. Rosen, Navneet K. Dhillon, David S. Hong, Anne Blackwood‐Chirchir, Feng Luo, Oumar Sy, Sanjeev Kaul, Alberto Chiappori	2010	104
19	Biomarker Analyses in Phase 2 Single-Agent Trials of Dasatinib for Breast Cancer. Cancer Research ·Lewis C. Strauss, Oumar Sy, Justin Fairchild, Merl Herlina, ESRA GÜRKAŞ, Sangeetha Yoganathan, Daniel Brickman, Rashmi Saikhedkar, Lynn Ploughman	2009	3
20	Prevention of the Epidemic Increase in Child Risk of Overweight in Low-Income Schools Archives of Pediatrics and Adolescent Medicine ·Karen J. Coleman, C J Hobel, Jeśús Salas Sánchez, Edward M. Heath, Oumar Sy, George A. Milliken, David A. Dzewaltowski	2005	188

About Oumar Sy

Oumar Sy is a scholar working on Hematology, Genetics, Forestry, Critical Care and Intensive Care Medicine and Oncology, having authored 53 papers that have together received 1.3k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (19 papers), Chronic Lymphocytic Leukemia Research (15 papers), Eosinophilic Disorders and Syndromes (8 papers), Multiple Myeloma Research and Treatments (7 papers), HER2/EGFR in Cancer Research (7 papers), Cancer Treatment and Pharmacology (5 papers), Agriculture and Rural Development Research (5 papers) and Respiratory Support and Mechanisms (4 papers). The work is most often cited by research in Hematology (424 citations), Genetics (246 citations), Oncology (526 citations), Critical Care and Intensive Care Medicine (48 citations) and Rheumatology (128 citations). Oumar Sy has collaborated with scholars based in United States, France and Germany. Frequent co-authors include Lewis C. Strauss, Joseph A. Sparano, Justin Fairchild, David A. Dzewaltowski, Karen J. Coleman, Carmelo Bengala, Edward M. Heath, George A. Milliken, Jeśús Salas Sánchez and Henri Roché. Their work appears in journals such as Blood, HemaSphere, Journal of Clinical Oncology, Clinical Cancer Research and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact